Richman Michael
Insider CIK 1366265 · OPXA Director · PIRS Director · NXTC President & CEO, Director · GNVC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NXTC NextCure, Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 38,190 | — | $0 | 38,190 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2025-01-31 | 2025-02-03 | 305,500 | — | $0 | 305,500 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2024-03-29 | 2024-04-02 | 244,400 | — | $0 | 244,400 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2024-01-31 | 2024-02-01 | 305,500 | — | $0 | 305,500 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2023-02-28 | 2023-03-01 | 309,000 | — | $0 | 309,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 262,400 | — | $0 | 262,400 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2021-06-25 | 2021-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2021-03-15 | 2021-03-16 | 300,000 | — | $0 | 300,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-06-23 | 2020-06-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2020-02-28 | 2020-03-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-01-25 | 2020-01-28 | 5,431 | $2.11 | $11.5K | 5,431 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-01-25 | 2020-01-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-10-25 | 2019-10-28 | 5,165 | $2.12 | $10.9K | 5,165 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-07-25 | 2019-07-26 | 3,789 | $2.89 | $11.0K | 3,789 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-04-25 | 2019-04-30 | 5,640 | $1.94 | $10.9K | 5,640 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-29 | 6,096 | $1.79 | $10.9K | 6,096 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-10-25 | 2018-10-29 | 3,829 | $2.86 | $11.0K | 3,829 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-07-25 | 2018-07-26 | 2,837 | $3.86 | $11.0K | 2,837 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-04-25 | 2018-04-26 | 2,665 | $4.10 | $10.9K | 2,665 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-01-25 | 2018-01-29 | 2,243 | $5.09 | $11.4K | 2,243 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-01-25 | 2018-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-10-25 | 2017-10-27 | 4,006 | — | $0 | 4,006 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-07-25 | 2017-07-27 | 3,288 | — | $0 | 3,288 | SEC↗ |
| GNVC GENVEC INC | M Exercise deriv | 2017-06-16 | 2017-06-20 | 2,250 | $3.80 | $8.6K | 0 | SEC↗ |
| GNVC GENVEC INC | D To issuer | 2017-06-16 | 2017-06-20 | 1,061 | — | $0 | 0 | SEC↗ |
| GNVC GENVEC INC | M Exercise | 2017-06-16 | 2017-06-20 | 2,250 | $3.80 | $8.6K | 2,250 | SEC↗ |
| GNVC GENVEC INC | F Tax w/h | 2017-06-16 | 2017-06-20 | 1,189 | $7.19 | $8.5K | 1,061 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-04-25 | 2017-04-27 | 7,821 | — | $0 | 7,821 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-01-25 | 2017-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-01-25 | 2017-01-30 | 9,687 | — | $0 | 9,687 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-10-25 | 2016-10-27 | 9,656 | — | $0 | 9,656 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2016-10-20 | 2016-10-24 | 22,500 | — | $0 | 22,500 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-09-30 | 2016-10-04 | 6,455 | — | $0 | 25,884 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-07-25 | 2016-08-01 | 9,144 | — | $0 | 9,144 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-06-30 | 2016-07-01 | 6,455 | — | $0 | 19,429 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2016-05-16 | 2016-05-18 | 6,455 | — | $0 | 12,974 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-04-27 | 2016-04-29 | 7,679 | — | $0 | 7,679 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-02-16 | 2016-02-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2016-01-15 | 2016-01-20 | 9,654 | — | $0 | 9,654 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-12-31 | 2016-01-04 | 1,354 | — | $0 | 6,520 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2015-11-13 | 2015-11-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2015-10-15 | 2015-10-30 | 8,267 | — | $0 | 8,267 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-09-30 | 2015-10-02 | 1,200 | — | $0 | 5,166 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2015-07-15 | 2015-07-17 | 6,310 | — | $0 | 6,310 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-06-30 | 2015-07-01 | 8,427 | — | $0 | 31,729 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2015-04-21 | 2015-04-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 8,242 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise deriv | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 0 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | M Exercise | 2015-04-08 | 2015-04-09 | 8,242 | — | $0 | 23,302 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2015-03-31 | 2015-04-01 | 6,818 | — | $0 | 15,060 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 23,804 | — | $0 | 23,804 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2015-03-30 | 2015-04-01 | 71,410 | — | $0 | 71,410 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 5,896 | — | $0 | 5,896 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2014-02-28 | 2014-03-04 | 17,686 | — | $0 | 17,686 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award | 2014-02-28 | 2014-03-04 | 8,242 | — | $0 | 8,242 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 17,143 | — | $0 | 17,143 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2013-04-29 | 2013-05-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPXA Opexa Therapeutics, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 20,600 | — | $0 | 20,600 | SEC↗ |